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XIAPSkeletalmuscle differentiation requires activity of the apoptotic protease caspase-3.We attempted to identify the
source of caspase activation in differentiating C2C12 skeletal myoblasts. In addition to caspase-3, caspase-2 was
transiently activated during differentiation; however, no changes were observed in caspase-8 or -9 activity. Al-
though mitochondrial Bax increased, this was matched by Bcl-2, resulting in no change to the mitochondrial
Bax:Bcl-2 ratio early during differentiation. Interestingly, mitochondrial membrane potential increased on a
timeline similar to caspase activation and was accompanied by an immediate, temporary reduction in cytosolic
Smac and cytochrome c. Since XIAP protein expression dramatically declinedduringmyogenesis,we investigated
whether this contributes to caspase-3 activation. Despite reducing caspase-3 activity by up to 57%, differentiation
was unaffected in cells overexpressing normal or E3-mutant XIAP. Furthermore, a XIAPmutantwhich can inhibit
caspase-9 but not caspase-3 did not reduce caspase-3 activity or affect differentiation. Administering a chemical
caspase-3 inhibitor demonstrated that complete enzyme inhibitionwas required to impairmyogenesis. These re-
sults suggest that neither mitochondrial apoptotic signaling nor XIAP degradation is responsible for transient
caspase-3 activation during C2C12 differentiation.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Apoptosis is a tightly controlled physiological process that typically
results in the removal of abnormal, damaged, and/or unnecessary cells
[1]. Upstreamapoptotic events converge on a set of proteolytic enzymes
known as caspases, which cleave various proteins leading to DNA dam-
age and cell disassembly. Caspases become activated in response to the
binding of extracellular death ligands, and as a result of intracellular
stressors sensed by the mitochondria and endoplasmic reticulum
[2–5]. Cells possess a number of anti-apoptotic capabilities, and this bal-
ance between pro- and anti-apoptotic signaling determines the extent
of caspase activation and ultimately cell death [1]. During development,
apoptosis is responsible for shaping tissues by eliminating cells deemed
unnecessary. However, evidence suggests that apoptotic signaling con-
tributes to differentiation in several cell types including some epithelial
tissues, erythrocytes, and skeletal muscle [6].
Skeletal muscle differentiation occurs during embryonic develop-
ment whereby a population of single-nucleated stem cell-like myo-
blasts exit cell cycle and fuse to form multinucleated myotubes. This
process is controlled by a number of hormones, cell cycle regulators,
speciﬁc inhibitor of differentiation (Id) proteins, and transcriptionlogy, University of Waterloo,
anada. Tel.: +1 519 888 4567;
).factors (i.e. MyoD, Myf-5, MRF-4, and myogenin) known as myogenic
regulatory factors (MRFs) [7,8]. As with other tissue types, widespread
cell death occurs in skeletal muscle during development. Interestingly,
MyoD has been shown to regulate apoptotic signaling in cells that die
during the differentiation process [9,10]. Furthermore, several pheno-
typic alterations typical of apoptosis also occur in surviving cells during
myogenesis. This includes cytoskeletal reorganization [11], activation of
matrix metalloproteinases [12], and the extracellular exposure of
phosphatidylserine [13].
In fact, previous studies have shown that caspase activation, partic-
ularly caspase-3, is required for skeletal muscle formation [14]. In this
seminal paper, primary myoblasts taken from caspase-3 null mice did
not form myotubes or express markers of differentiation [15]. Further-
more, a caspase-3 substrate, MST1, was shown to be cleaved, and the
provision of its active product partially restored differentiation in
caspase-3 null cells [15]. Since then, other pro-differentiation caspase
targets have been identiﬁed. This includes the bHLH transcription factor
Twist, which inhibits MyoD and MEF2 [16,17], the MEF2 repressor
HIPK2 [18], and the typically pro-apoptotic target CAD, which is neces-
sary for proper induction of p21 [19].
Aside from substrate speciﬁcity, it has been suggested that theman-
ner of caspase activation determines the “die or differentiate” decision
[14]. Caspase activity during differentiation occurs transiently and re-
portedly at a lower intensity than during apoptosis [14,15,20]. There-
fore, it may be this ﬁne-tuning of apoptotic signaling that allows
surviving cells to avoid death and instead progress through the
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becomes active in differentiating cells, and how this signaling is main-
tained transiently. Previous studies have implicated the involvement
of typical apoptotic mechanisms such as Bcl-xL/caspase-9 [20] and
FADD/caspase-8 [21]. However, speciﬁc hallmarks such asmitochondri-
al permeabilization and release of pro-apoptotic factors have not been
shown in differentiating myoblasts.
Therefore, the purpose of this study was to assess typical apoptosis
signaling in differentiating skeletal muscle cells to identify the relevant
source of caspase activation. Based on initial observations, we further
examined the role XIAP may play in this context.
2. Materials and methods
2.1. Cell culture
C2C12 mouse skeletal myoblasts (ATCC) were cultured in growth
media (GM) consisting of low-glucoseDulbecco'sModiﬁed Eagle'sMedi-
um (DMEM; Hyclone, ThermoFisher) containing 10% fetal bovine serum
(FBS; ThermoFisher) and 1% penicillin/streptomycin (ThermoFisher) on
polystyrene cell culture dishes (BD Biosciences). Upon reaching 80–90%
conﬂuence, differentiation was induced by replacing GMwith differen-
tiation media (DM) consisting of DMEM supplemented with 2% horse
serum (Hyclone, ThermoFisher) and 1% penicillin/streptomycin. Cells
were isolated andutilized for various biochemical analyses immediately
prior to the induction of differentiation (day 0), and at several subse-
quent time points. In some experiments C2C12 cells were treated
with staurosporine (2 μM, Enzo Life Sciences), oligomycin (2.5 μM or
10 μM, Cayman Chemical), or the caspase-3 inhibitor Ac-DEVD-CHO
(5 μM, 10 μM, or 30 μM, Enzo Life Sciences).
2.2. Isolation and subcellular fractionation
In order to avoid the potential effects of apoptotic events happening
in cells which die during differentiation, cells in culture were always
washed three times with warmed PBS before being removed for analy-
ses. Afterwashing, cells were isolated via trypsinization and centrifuged
at 1000 g. Whole-cell lysates were generated by adding lysis buffer (LB,
pH 7.4; 20mMHEPES, 10mMNaCl, 1.5 mMMgCl, 1 mMDTT, 20% glyc-
erol, and 0.1% Triton-X100, Sigma Aldrich) with protease inhibitors
(Complete Cocktail; Roche) followed by sonication for 20 s.
Additional cells were separated into cytosolic-, mitochondrial-, and
nuclear-enriched fractions [22,23]. After trypsinization and washing,
cells were incubated in digitonin buffer (PBS with 250 mM sucrose,
80 mM KCl, and 50 μg/mL digitonin, Sigma Aldrich) for 5 min on ice.
Cellswere centrifuged at 1000 g for 10min, the supernatantwas collect-
ed and centrifuged at 16,000 g for 10 min to pellet any mitochondrial
contamination, and the supernatant from this spin was kept as the
cytosolic-enriched fraction. The pellet (P1) remaining from the 1000 g
spin was washed in PBS, centrifuged at 1000 g for 5 min, resuspended
in LB, and allowed to sit on ice for 5 min. This was centrifuged at
1000 g for 10 min, resulting in a pellet (P2) containing nuclei, and a su-
pernatant (S2) containing mitochondria. S2 was centrifuged at 1000 g
for 10 min to pellet nuclear contamination, with the resulting superna-
tant kept as the mitochondrial-enriched fraction. The P2 pellet was re-
suspended in LB, centrifuged at 1000 g for 10 min, again suspended in
LB, sonicated for 20 s, and kept as the nuclear-enriched fraction.
Protein content of whole cell lysates and fractions was determined
using the BCA protein assaymethod. Subcellular fraction puritywas val-
idated by immunoblotting for actin (cytosol), MnSOD (mitochondria),
and histone H2B (nucleus).
2.3. Immunoblotting
Immunoblotting was performed as previously described [22]. Mem-
branes were probed with primary antibodies against AIF, Apaf1, ARC,ANT, Bcl-2, Bax, cytochrome c, MDM2, MyoD, p53 (Santa Cruz), histone
H2B, MnSOD, Smac, XIAP (Enzo Life Sciences), myosin, myogenin (De-
velopmental Studies Hybridoma Bank), actin (Sigma Aldrich), FLAG,
HA (Cell Signaling), or PUMA (Abcam). Membranes were then incubat-
ed with the appropriate horseradish peroxidase (HRP)-conjugated sec-
ondary antibody (Santa Cruz), and bands were visualized using
enhanced chemiluminescence (ECL) immunoblotting detection re-
agents (BioVision) and the ChemiGenius 2 Bio-Imaging System
(Syngene). The approximate molecular weight for each protein was es-
timated using Precision Plus Protein WesternC Standards and Precision
Protein Strep-Tactin HRP Conjugate (Bio-Rad Laboratories). Equal load-
ing and quality of transfer were conﬁrmed by stainingmembranes with
Ponceau S (Sigma Aldrich).
2.4. Caspase activity
Enzymatic activity of caspase-2, -3, -8, and -9 was determined using
the substrates Ac-VDVAD-AMC, Ac-DEVD-AMC, Ac-IETD-AMC, and Ac-
LEHD-AMC (Enzo Life Sciences), respectively [22]. Cells were isolated
as mentioned above using LB without addition of protease inhibitors,
and incubated in duplicate in black 96-well plates with the appropriate
ﬂuorogenic substrate at room temperature. Fluorescencewasmeasured
with excitation and emission wavelengths of 360 nm and 440 nm, re-
spectively. Caspase activity was normalized to total protein content
and expressed as ﬂuorescence intensity in arbitrary units (AU) per mil-
ligram protein.
2.5. Transfections and plasmids
C2C12 cells were transfected with various plasmids (Addgene)
to modify XIAP expression. Transfections were performed with
Lipofectamine 2000 (Life Technologies) optimized according to the
manufacturer's instructions. A transfection efﬁciency of 50–60% was
generally achieved. Cells were transfected upon reaching 50–60% con-
ﬂuence and differentiation was induced the following day. Plasmids
used included: pEBB-FLAG-XIAP (encoding full-length humanXIAP pro-
tein, hXIAP), pEBB-FLAG-XIAP-D148A (mutation which prevents XIAP
from binding caspase-3), pEBB-HA-XIAP-H467A (mutation which pre-
vents XIAP's E3 ubiquitin ligase activity), and pEBB-GFP (control).
C2C12 cells stably expressing GFP-tagged cytochrome c (Cytc-GFP)
were generated using retroviral transduction. Brieﬂy, Phoenix helper-
free retrovirus packaging cells were transfected as outlined above
with pCytochrome C-GFP [24]. Two days post-transfection, Phoenix
cell media was harvested, ﬁltered, and used to transduce C2C12 cells.
Stably transduced Cytc-GFP expressing C2C12 clones were selected
with puromycin (Sigma Aldrich).
2.6. Immunoﬂuorescent and live-cell microscopy
Fluorescent microscopy was used to visualize nuclei and expression
ofmyosin. Cells grown on gelatin-coated glass coverslips were removed
from culture at appropriate time points and incubated with a myosin-
speciﬁc antibody (Developmental Studies Hybridoma Bank) diluted in
10% goat serum in PBS for 1 h. Cells were then incubated with a
ﬂuorescent-conjugated secondary antibody (Santa Cruz) for 1 h, coun-
terstained with DAPI (Life Technologies) to identify nuclei, and
mounted with Prolong Gold Antifade Reagent (Life Technologies). Im-
ages were captured with an Axio Observer Z1 ﬂuorescent microscope
equipped with standard Red/Green/Blue ﬁlters, an AxioCam HRm cam-
era, and AxioVision software (Carl Zeiss).
Cytochrome c visualization was performed in live C2C12 cells stably
expressing Cytc-GFP (detailed above) using the aforementioned ﬂuo-
rescent microscope with optical sectioning through structured illumi-
nation (Carl Zeiss). Live imaging was performed in a temperature- and
humidity-controlled microscope-mounted chamber maintained at
37 °C and 5% CO2.
2928 D. Bloemberg, J. Quadrilatero / Biochimica et Biophysica Acta 1843 (2014) 2926–29362.7. Cell fusion index
Images stained with myosin and DAPI were used to determine the
degree of myoblast fusion by counting all nuclei in ﬁve random micro-
scopic ﬁelds per experiment. Nuclei were categorized as follows:
single-nucleated myosin negative (unfused), single-nucleated myosin
positive (unfused with myosin), or multi-nucleated myosin positive
(fused).
2.8. Flow cytometry
Cells were harvested as described above and suspended in Hank's
Balanced Salt Solution (HBSS). Mitochondrial membrane potential and
mitochondrial permeability transition pore formation were measured
using JC-1 and calcein, respectively, as previously performed [22]. Mito-
chondrialmembrane depolarization can bemonitored by changes in the
JC-1 red:green ﬂuorescence ratio, where a decreased ratio is indicative
of decreased mitochondrial membrane potential. Brieﬂy, cells were
incubatedwith 2 μM JC-1 in HBSS for 15min at 37 °C, washed by centri-
fugation, and resuspended in HBSS. As a positive control for membrane
depolarization, cells were incubated with JC-1 and the mitochondrial
uncoupler CCCP (Enzo Life Sciences). Mitochondrial permeabilityDay 0
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-3 activities were temporarily elevated during differentiation. (E) DNA fragmentation in adhertransition pore (mPTP) formation occurs during mitochondrial-
mediated apoptosis prior to mitochondrial apoptotic protein release.
The ﬂuorescent dye calcein AM accumulates in intact mitochondria,
but is quenched by cobalt if themitochondrial membrane becomes per-
meable to cobalt. Thus a decrease in calceinﬂuorescence indicatesmPTP
formation. Brieﬂy, cells were incubatedwith 1 μMcalcein AM and 1mM
CoCl2 in HBSS for 15 min at 37 °C, washed by centrifugation, and resus-
pended in 500 μL HBSS.
For analysis of Ac-DEVD-CHO toxicity, Annexin-V/PI staining was
performed [22]. After treatment, cells were suspended in buffer
(10 mM HEPES/NaOH, 150 mM NaCl, 1.8 mM CaCl2, pH 7.4) and incu-
bated with 5 μL of Annexin V-FITC (Life Technologies) and 1 μL of
500 μg/mLpropidium iodide (PI). Therewere nodifferences in the num-
ber of healthy or dead cells as measured using Annexin V/PI staining in
cells incubatedwith Ac-DEVD-CHO for up to 2 days (data not shown). All
analyses were performed on a ﬂow cytometer (BD FACSCalibur)
equipped with Cell Quest Pro software (BD Bioscience).
2.9. DNA fragmentation
Cytoplasmic histone-associated mono- and oligonucleosomes were
determined using the Cell Death Detection ELISAPLUS Kit (Roche) asDay 1 Day 2
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supplied lysis buffer and centrifuged at 200 g for 10 min. Supernatant
was incubated with anti-histone-biotin/anti-DNA-POD reagent in a
streptavidin-coated microplate for 2 h at room temperature under gen-
tle shaking. The solution was then removed, wells were washed several
times, and 100mL of ABTS substrate solutionwas added to eachwell. As
a control for DNA fragmentation, a sample containing a DNA–histone-
complex was included and produced a strong positive signal. Absor-
bance was measured at 405 nm and 490 nm and normalized to total
protein content and expressed as AU per mg protein.2.10. Cell counting/size analysis
Cell counts were performed with a Z2 Coulter Counter (Beckman–
Coulter) to ensure accurate seeding densities and assess the number
of dead cells contained in culture media. Cells between 12–19 μm
were considered viable and plated at appropriate densities and dead
cells were determined by counting events between 5–12 μm.2.11. Statistical analyses
All results shown are means ± standard error of the mean (s.e.m.),
where n = 3 for each experiment. Data were analyzed using one-way
ANOVA and Tukey's post-hoc analysis with p b 0.05 considered statisti-
cally signiﬁcant. For experiments characterizing apoptotic signaling
during differentiation, comparisons were made between day 0 and
each subsequent time point. For other experiments, comparisons were
made between indicated treatment groups. Analyses were performed
using GraphPad Prism.A
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3.1. C2C12 differentiation is associated with temporary activation of
caspases
Switching C2C12 cells to DM induced typical differentiation-
associated changes such as progressively increased myosin, decreased
MyoD, and transientmyogenin protein expression (Fig. 1A). Additional-
ly, immunoﬂuorescentmicroscopy ofmyosin showed that myotube de-
velopment peaked on day 7, where 57% of nuclei were contained in
multi-nucleated cells (Fig. 1B,C). The transient activation of caspase-3
typical of differentiation was also observed (Fig. 1D). In contrast with
previous reports [20,21], signiﬁcant changes to caspase-8 and -9 activi-
ties did not occur (Fig. 1D). However, caspase-2 activity increased
0.5 days after inducing differentiation, and remained elevated by 45–
51% (p b 0.05) until day 1.5 (Fig. 1D). Finally, although this temporary
caspase activity has been suggested to be too low to cause damaging ap-
optotic features, the level of DNA fragmentation in adhered cells was el-
evated (p b 0.05) 4.6-fold and 3.6-fold, respectively, on days 1 and 2 of
differentiation (Fig. 1E). The increase (p b 0.05) in DNA fragmentation
observed on day 7 is likely a consequence of the time spent in culture.
3.2. Changes to pro- and anti-apoptotic proteins during differentiation
Differentiation was associated with the rapid appearance of p53 and
the disappearance of MDM2, a ubiquitin ligase which targets p53
(Fig. 2A,B). Two genes controlled by p53 are the pro-apoptotic Bcl-2
family members Bax and PUMA [25,26]. The protein expression of Bax
and PUMA was increased (p b 0.05) 16% and 23%, respectively, on day
1 compared to day 0 (Fig. 2A,C). However, the expression of Apaf1, a
protein which contributes to caspase-9 activation, did not change3 5 7
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niﬁcance (p b 0.05) on days 5 and 7 (Fig. 2A,C). In addition, the protein
levels of several mitochondrial pro-apoptotic factors (AIF, Smac, cyto-
chrome c) changed similarly to markers of mitochondrial content
(ANT, MnSOD), which is known to increase during myotube develop-
ment [27] (Fig. 2D). The expression of two anti-apoptotic proteins
(Bcl-2 and ARC) which can act upstream of mitochondrial disruption
was elevated (p b 0.05) as caspase activity decreased, with Bcl-2 in-
creasing 2.5-fold by day 2 of differentiation and ARC progressively in-
creasing 5.6-fold by day 7 (Fig. 2E,F). Importantly, XIAP, which acts
downstream of the mitochondria by inhibiting caspases, decreased
(p b 0.05) by 51% by day 2 and continued to decline throughout differ-
entiation (Fig. 2E,F).A
Day 0 1 1.5 2 3 5
Bcl-2
26kDa
Bax
19kDa
Ponceau
Mitochondria
0.5
AIF
62/57kDa
Smac
19kDa
Ponceau
Cy
Cyt-c
14kDa
Actin
42kDa
MnSOD
23kDa
Day 0 10.5
Days of Dif
M
ito
ch
on
dr
ia
l
B
ax
/B
cl
-2
 R
at
io
D
0 0.5 1 1.
0
1
2
3
4
5
6
7
0 1 2 3 4 5
0
1
2
3
4
*
*
Days of Differentiation
JC
-1
R
ed
:G
re
en
Fl
uo
re
sc
en
ce
R
at
io
(A
U
) E
G H
B
Cyt-c
14kDa
Actin
42kDa
MnSOD
23kDa
Day 0
Cyto Mito C
Total
0 1 1.5 20.5Day
0 1 2
0
1
2
3
4
5
6
7 Total
Mito
Days of Differentiation
P
ro
te
in
 E
xp
re
ss
io
n 
(A
U
)
*
$
Mito
Cyt-c
14kDa
$
*
Fig. 3.Markers of mitochondrial-mediated apoptosis do not increase following the induction o
change early during differentiation. (C) Calcein ﬂuorescence increasedmidway through the diff
brane potential was transiently increased early during differentiation. (E and F) Cytosolic leve
differentiation. (G) Cytochrome c expression inmitochondrial-enriched fractions (Mito) increa
tiation. (H) Equal amounts of cytosolic (Cyto) and mitochondrial (Mito) fraction extracts were
bution during the ﬁrst 2 days of differentiation is readily apparent. (I) Validation that subcellu
staurosporine (STS) for 3 h and fractions were attained as outlined in Materials and methods. A
pared to day 0; $p b 0.05 compared to all other days.3.3. Markers of mitochondrial-mediated apoptosis do not increase
following the induction of differentiation
As the functional relevance of several apoptosis-regulating factors
depends on their cellular localization, we next examined the content
of select proteins in subcellular fractions. Although whole-cell (Fig. 2A,
C) and mitochondrial (Fig. 3A) Bax increased (p b 0.05) 1 day after in-
ducing differentiation, mitochondrial Bax was matched by Bcl-2 during
the early days of differentiation, resulting in no change to the Bax:Bcl-2
ratio (Fig. 3A,B). This result suggests that any apoptotic action of Bax
was likely inhibited prior to caspase activation. In accordance with
this, mitochondrial permeability transition pore (mPTP) formation did
not increase early during differentiation (Fig. 3C). In fact, calceintosol
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process, likely due to elevated mitochondrial content (Fig. 3C). Addi-
tionally, mitochondrial membrane potential transiently increased
(p b 0.05) up to 3.2-fold by day 1 of differentiation (Fig. 3D).
Ultimately, mitochondrial disruption stimulates apoptosis by releas-
ing several cell death promoting proteins. Cytosolic levels of Smac and
cytochrome c declined (p b 0.05) 55% and 60%, respectively, on day
0.5 and remained lowered during the spike in caspase activity (Fig. 3E,
F). Similar changes to AIF localization were not observed (Fig. 3E,F). In-
terestingly, although total cytochrome c protein levels increased 2.1-
fold in the ﬁrst 2 days of differentiation similar to the mitochondrial
markers MnSOD and ANT (Fig. 2D), mitochondrial-speciﬁc cytochrome
c was elevated 6.6-fold (Fig. 3G). In fact, immunoblotting with equal
amounts of cellular extract demonstrated that cytochrome c became
less cytosolic and more mitochondrial-localized early during differenti-
ation (Fig. 3H). To ensure that subcellular fractions detected proper ap-
optotic signaling, C2C12 cells were treated with 2 μM staurosporine
(STS) for 3 h. As shown, STS resulted in elevated cytosolic AIF (the
57 kDa isoform), Smac, and cytochrome c, as well as increased mito-
chondrial Bax compared to untreated cells (CTRL) (Fig. 3I).
3.4. Translocation of Cytc-GFP in stably transduced C2C12 cells
The decrease in cytosolic cytochrome c was further illustrated in
C2C12 cells stably expressing a GFP-cytochrome c fusion protein
(Cytc-GFP). Notably, we found that in stably selected clones, myoblasts
with mitochondrial-localized GFP were rare (see Fig. 4, bottom left
panel). However, time-lapse imaging of live cells with mitochondrial-
GFP revealed that treatment with staurosporine (STS, 2 μM, 3 h) appro-
priately induced Cytc-GFP release (Fig. 4, top panels). Most importantly,
during the ﬁrst 1.5 days of differentiation, Cytc-GFP became
mitochondrial-localized in myoblasts with initially non-mitochondrial
Cytc-GFP expression (Fig. 4, bottom panels).
3.5. Mitochondrial hyperpolarization stimulates cytochrome c
translocation to the mitochondria
The observation that differentiation was associated with transiently
increased mitochondrial membrane potential and reduced cytosolic
levels of cytochrome c was not expected, thus we examined whether
these events were related. Incubation of cells with CCCP dramatically
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in the JC-1 red:green ratio). C2C12 cells treated for 6 h with 2.5 μM or
10 μM oligomycin, an ATP synthase inhibitor, displayed increased
(p b 0.05) red:green ﬂuorescence ratio of JC-1 by 3.3-fold and 2.6-fold,
respectively, indicating mitochondrial hyperpolarization (Fig. 5A). Fur-
thermore, oligomycin treatment resulted in decreased cytosolic and in-
creasedmitochondrial cytochrome c protein levels (Fig. 5B). As a result,
the ratio of mitochondrial to cytosolic cytochrome c protein increased
(p b 0.05) 2.7-fold and 3.0-fold in response to 2.5 μM and 10 μM
oligomycin, respectively (Fig. 5B).
3.6. XIAP's E3 ubiquitin ligase activity regulates its degradation and caspase
inhibitory effects during C2C12 differentiation
Given the lack of upstream mitochondrial apoptotic signaling, we
examined XIAP's role in regulating caspase-3 activity and myoblast dif-
ferentiation as its protein expression declined dramatically during
myogenesis. C2C12 cells were transfected with speciﬁc plasmids to in-
troduce human XIAP (hXIAP), and two XIAPmutants (D148A: impaired
caspase-3 binding; H467A: deﬁcient E3 ligase activity). Control cells
were transfected with a similar vector encoding GFP. We generally
achieved levels of exogenous XIAP that resulted in a 50–100% increase
in total XIAP expression 24 h post transfection (Fig. 6A). Although
both hXIAP and D148A were degraded on a similar timeline to endoge-
nous XIAP (Fig. 6B,C), H467A expression was maintained during differ-
entiation (Fig. 6B,C), suggesting that self-ubiquitination is responsible
for XIAP disappearance during differentiation. While cells transfected
with D148A displayed similar caspase-3 activity as GFP control cells,
hXIAP induced a 57% reduction (p b 0.05) in total caspase-3 activity
compared to controls during differentiation (Fig. 6D,E). Additionally, al-
thoughwe hypothesized the degradation-resistant H467Awould result
in an even greater inhibition of caspase-3, it reduced (p b 0.05) activityD
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ly different (p b 0.05) than the inhibition achieved by hXIAP (Fig. 6D,E).
3.7. Reduction of caspase-3 activity with exogenous XIAP does not alter
myoblast differentiation
Immunoﬂuorescent visualization of myosin and quantiﬁcation of
cell fusion events after 5 days of differentiation indicated that, despite
partially inhibiting caspase-3 activity, myotube formation was not
prevented by XIAP transfections (Fig. 7A,B). In agreementwith this, im-
munoblotting analyses demonstrated that the expression of muscle dif-
ferentiation markers was not different between groups (Fig. 7C,D).
3.8. Complete inhibition of caspase-3 is necessary to affect myoblast
differentiation
We subsequently tested whether the degree of enzyme inhibition
determines the impact on myogenesis. C2C12 cells differentiated with
increasing amounts of Ac-DEVD-CHO displayed progressively less
(p b 0.05) caspase-3 activity during myogenesis (Fig. 8A). Although
5 μM and 10 μM of inhibitor did not affect myotube formation, 30 μM
Ac-DEVD-CHO reduced (p b 0.05) cell fusion on day 5 compared to all
other groups (Fig. 8B,C). Similarly, myosin protein expression was de-
creased (p b 0.05) on days 3 and 5, while myogenin was decreased
(p b 0.05) on days 2 and 3 in cells receiving 30 μM of the inhibitor
(Fig. 8D,E).
4. Discussion
In this study we investigated the biologically-relevant cause for
caspase-3 activation in differentiating C2C12 myoblasts. While apopto-
tic signaling in differentiating skeletal muscle has been examinedC
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and release of pro-apoptotic factors have not been shown. Furthermore,
studies have implicated speciﬁc apoptoticmechanismswithout showing
their respective activation in unmodiﬁed cells. Although it was hypothe-
sized that one ormore of these apoptosis-regulatingmechanisms would
be observed, myogenesis was associated with a reduction in several
apoptosis-promoting indices.
In agreement with our initial hypothesis, caspases were transiently
activated, p53-controlled pro-apoptotic proteins temporarily increased,
and the decline in caspase activity coincided with increased expression
of two multi-functional anti-apoptotic proteins, Bcl-2 and ARC. Howev-
er, subsequent analyses did not detect elevated levels of apoptosis-
promoting events, speciﬁcally those related to mitochondrial signaling.
Previously, several apoptotic mechanisms have been reported dur-
ing muscle differentiation. In particular, shRNA against caspase-9 as
well as Bcl-xL overexpression prevented transient caspase-3 activation
and delayed cell fusion during C2C12 differentiation [20]. However,
the appearance of myosin-positive myoblasts and the total protein ex-
pression of myosin and myogenin were not altered in these experi-
ments. Using 23A2 cells, another myogenic mouse line, others have
observed cytochrome c release 2 h after inducing differentiation [28].
Although, preventing cytochrome c release with shRNA-mediated
PUMA knockdown as well as complete caspase-9 inhibition with a
chemical enzyme inhibitor did not impair differentiation [28]. This
group also showed that inhibition of caspase-8 and cells dominant neg-
ative for FADD displayed decreased myosin and MyoD protein expres-
sion, suggesting the involvement of death-receptor signaling during
myoblast differentiation [21]. Despite using similar culturing techniques
as Murray et al. [20], we found that Bax expression and mitochondrialtranslocation were matched by Bcl-2, ﬂow cytometric analyses of
calcein and JC-1 did not detect an increase in mPTP formation or a
drop in mitochondrial membrane potential, cytosolic levels of cyto-
chrome c and Smac protein dramatically decreased, and neither Apaf1
expression or caspase-9 activity increased during differentiation.
These ﬁndings suggest that mitochondrial apoptotic signaling is not ac-
tive in differentiating C2C12 cells. Additionally, we did not detect ele-
vated levels of caspase-8 activity at any time point of differentiation.
Indeed, these studies highlight the need to identify the mechanisms of
caspase activation in unmodiﬁed differentiating muscle. In fact, while
skeletal muscle development is impaired in caspase-3 knockout mice
[15], caspase-9 null mice possess mature skeletal muscle [29], and
micewithout caspase-8 do not presentwith obvious skeletalmuscle de-
fects [30]. Ultimately, given the redundant cleavage-site speciﬁcities of
caspases, compensatory activities may be relevant during genetic and
pharmacological manipulations, perhaps leading to “delayed” instead
of “prevented” muscle development phenotypes. Currently, these ob-
servations emphasize the need for subsequent analyses.
Examination of mitochondrial apoptotic signaling introduced sever-
al intriguing questions. Primarily, the dramatic reduction in cytosolic cy-
tochrome c and Smac upon the induction of differentiation was
unexpected. Previously, work has shown that these two pro-apoptotic
proteins were undetectable in cytosolic fractions of subconﬂuent and
differentiating C2C12 cells [20]. However, we detected both proteins
in cytosols of untreatedC2C12 cells and found that staurosporine appro-
priately induced mitochondrial release of both. Additionally, by stably
expressing GFP-tagged cytochrome c in C2C12 cells, live-cell imaging
revealed increasedmitochondrial localization of Cytc-GFP during differ-
entiation. Typically, mitochondrial depolarization is associated with the
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drial hyperpolarization immediately after inducing differentiation, so
we testedwhether the opposite could be true. In fact, causingmitochon-
drial hyperpolarization by treating subconﬂuent C2C12 cells with
oligomycin for 6 h reduced cytosolic and increased mitochondrial cyto-
chrome c levels. Previously, oligomycin has been shown to prevent cy-
tochrome c release by a variety of apoptotic stressors [31,32]. Likely,
oligomycin introduces an energy stress, and cells move cytochrome c
to themitochondria to promote electron transport and ATP production.
Interestingly, oligomycin has also been shown to modestly raise
cardiolipin content in yeast [33]. Given cytochrome c's positive charge
[34], mitochondrial hyperpolarization could attract nearby cytosolic cy-
tochrome c proteins directly, functioning tomitigate short-term energy
need. Perhaps, myoblasts undergo a similar stress upon the induction of
differentiation, resulting in cytochrome c redistribution.
The absence of mitochondrial apoptotic signaling and activation of
typical initiator caspases in our experiments was surprising and sug-
gests an alternative mechanism of caspase-3 activation during C2C12
differentiation. Our results show that early during differentiation there
is an elevation in caspase-2, which has been shown to activate
caspase-3 directly through pro-domain interactions [35]. Further, an-
other initiator caspase, caspase-12, has been shown to be activated dur-
ing myogenesis [36]. Thus, these upstream caspases may contribute to
caspase-3 processing during muscle differentiation. Another possibility
is regulation of caspase-3without the involvement of upstreamapopto-
tic signaling and activation of initiator caspases. Indeed, several protein
families interact with caspases directly, and caspase function isadditionally regulated by post-translational modiﬁcations such as phos-
phorylation and ubiquitination [37]. Potentially, any of these factors
may modulate the cellular pool of caspase-3 during myogenesis and
lead to increased enzyme activity. Our ﬁndings show that the protein
expression of the anti-apoptotic factors Bcl-2, ARC, and XIAP changes
in speciﬁc patterns during C2C12 differentiation. Most intriguing of
these is XIAP, a cytosolic anti-apoptotic protein which inhibits the pro-
cessing and/or enzymatically active forms of caspases-3, -7, and -9 [38].
Since XIAP expression decreased during C2C12 differentiation, we test-
ed whether this contributes to caspase-3 activation by overexpressing
normal and mutated XIAP proteins. Interestingly, XIAP regulates its
own degradation through self-ubiquitination, which is made possible
due to a C-terminal RING domain [39]. Furthermore, mutated or partial
XIAP proteins containing dysfunctional RINGs impart protein stability
during situations of induced degradation [39,40]. Therefore, we exam-
ined the effects on caspase-3 activation and myoblast differentiation
caused by full-length human XIAP (hXIAP) and XIAP-H467A, a point-
mutant which maintains its caspase binding abilities but has deﬁcient
E3 ligase activity [39,41].
Compared to E3-competent mutants, which followed a pattern of
decreased expression similar to endogenous XIAP, protein levels were
maintained inH467A transfected cells duringdifferentiation, suggesting
that self-ubiquitination contributes to declining XIAP content. In fact, el-
evated proteasomal activity is required for myogenesis [42,43], and nu-
merous proteins, such as Pax3, MyoD, and Id1, are speciﬁcally targeted or
protected from degradation during myogenesis [44,45]. Although
declining XIAP levels could be explained by depressed protein synthesis,
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alterations contribute to reducing XIAP expression during muscle differ-
entiation. Therefore, it is likely that the E3-ligase activity of XIAP or its
susceptibility to ubiquitination is modulated during differentiation by
an unknown mechanism. Interestingly, we observed decreased cytosolic
Smac levels immediately after inducing differentiation. Given that Smac
is a primary regulator of XIAP function and ligase activity [46], this effect
would tend to promote XIAP's ligase activity and anti-apoptotic abili-
ties. Furthermore, XIAP is regulated by many growth and stress signal-
ing pathways including AKT, JNK, and ERK/MAPK [47–49], several of
which are involved with or altered during C2C12 differentiation [50].
Transfection of hXIAP resulted in less caspase-3 activity during dif-
ferentiation compared to H467A. It was hypothesized that H467A
would cause more caspase inhibition, as its protein levels were main-
tained during differentiation, and XIAP stability has been correlated
with its anti-apoptotic effectiveness [39]. However, in addition to
targeting itself for ubiquitination, XIAP functions as an E3-ligase for
caspase-3 [51], caspase-9 [52], and Smac [53], among others. As a result,
XIAP's ubiquitin ligase activity has been shown to be important for its
anti-apoptotic effects [40,51]. Therefore, XIAP-dependent caspase-3
ubiquitination may be relevant for its caspase-inhibiting functions dur-
ing periods of prolonged stress, such as that which occurs during
myogenesis.
Previous studies have demonstrated that various modes of caspase
inhibition prevent or delay muscle differentiation [15,19–21,54]. As
such, administering a high concentration of Ac-DEVD-CHO completely
prevented caspase-3 activation and subsequently impairedmyogenesis.
However, while caspase-3 activity was decreased in C2C12 cells with
hXIAP and H467A overexpression, differentiation was unaffected. This
is likely a result of insufﬁcient enzyme inhibition, as in experiments
where modest caspase-3 reduction was achieved with Ac-DEVD-CHO
treatment, myotube development occurred normally.
The D148A variant was selected to isolate the effect of caspase-3
inhibition. This point-mutation lies in XIAP's Linker-BIR2 region,
which is required for caspase-3 interaction [51,55]. Importantly,
this mutated XIAP features an intact BIR3 domain, and therefore
maintains caspase-9 binding ability [56]. When transfected into C2C12
cells prior to differentiation, D148Adid not reduce total caspase-3 activ-
ity compared to control cells transfectedwithGFP. Thisﬁnding provides
additional evidence supporting our conclusion that caspase-3 is not ac-
tivated by mitochondrial/caspase-9 apoptotic signaling during C2C12
differentiation.
5. Conclusion
This study serves as a comprehensive analysis of apoptotic effector
signaling during C2C12 differentiation. We found that mitochondrial-
mediated apoptotic signalingmechanisms did not precede the transient
caspase-3 activity associated withmyogenesis. Additionally, XIAP over-
expression did not impair myoblast differentiation, suggesting that its
degradation is likely not responsible for caspase activation in this con-
text. These ﬁndings emphasize the complex relationship between cell
death and differentiation, and provide the basis for future research.
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